Mankind Pharma Limited

Corporate

Verify this issuer →
Methodology v1.0 Download Report (PDF)
Latest Rating
AA (CRISIL)
Total Debt Outstanding
₹3,750 Cr
Across 2 instruments
Listed Bonds
2
First Issue
2024-10-16
Latest Issue
2024-10-16
Maturity Range
2026 - 2027
Observation
2 active bonds tracked from this issuer.
View details →
Coverage: High Data Quality: High Sources: NSE, BSE, SEBI, rating agencies
01 Issuer Overview
Sector
Issuer Type
Corporate
First Tracked Bond
2024-10-16
Start of this issuer's debt program timeline
  • 2 active bonds tracked from this issuer.
  • 2 of 2 tracked bonds with a stated security status are secured. (based on 2 bonds with a disclosed security status)

Mankind Pharma Limited is a corporate issuer. Coupon rates on outstanding bonds range from 7.97% - 7.99%, paid semi annual. Bonds mature between 2026 - 2027.

Data sourced from NSDL, BSE, NSE, and registered credit rating agencies. Verify against the issuer's offer document before transacting.

Thanks — your suggestion has been submitted for review.

02 Debt Profile
Outstanding Bonds
2
Tracked by RetailBonds
Amount Tracked
₹3,750 Cr
Of bonds tracked by RetailBonds — not the issuer's total outstanding debt
Avg Coupon
7.98%
Range 7.97% - 7.99%
Avg Remaining Tenure
0.7 Yrs
Nearest maturity 2026-10
Secured
100%
2 of 2 bonds with known status
Callable
0
Of 2 bonds
Avg Spread vs G-Sec
+241 bps
Credit premium (indicative)

Maturity Profile

Active bonds maturing, by year. Bar height relative to the tallest year (1 bonds).

0 2026: 1 bond, ₹1,250 Cr tracked, avg coupon 7.99% 1 bond 2026 2027: 1 bond, ₹2,500 Cr tracked, avg coupon 7.97% 1 bond 2027

Security Type / Instrument Mix

  • NCD 2 bonds · 100% · ₹3,750 Cr tracked

Funding Evolution

■ Issued that year — Cumulative outstanding (tracked)
2024: ₹3,750 Cr issued 2024 Cumulative: ₹3,750 Cr

Based on 2 of 2 active bonds with a known issue date and issue size.

03 Credit Profile
  • AA 2 bonds · 100%
AgencyRatingOutlookBonds
CRISIL AA 2
ICRA AA+ 2

Recent Rating Actions

No rating action history available.

04 Outstanding Bonds View all bonds →
ISIN Bond Name Coupon Rating Maturity YTM Last Trade
INE634S07025 MPL-7.99%-16-10-26-PVT 7.99% AA (CRISIL) 2026-10-16
INE634S07033 MPL-7.97%-16-11-27-PVT 7.97% AA (CRISIL) 2027-11-16 7.66% 2026-08-06
Compare (/) Compare Bonds

YTM and Last Trade depend on secondary-market volume — shown only for bonds with a recorded BSE/NSE trade.

05 Market Activity

Last 30 days, across all outstanding bonds from this issuer.

Traded Value (Last 30 Days)
₹0.0 Cr
Number of Trades (Last 30 Days)
1
Avg. Yield (Last 30 Days)
7.66%
06 Regulatory Filings
NSE Corporate Announcements
Other Restructuring 2026-08-26
General Updates 2026-08-22
Press Release 2026-08-20
General Updates 2026-08-17
Acquisition 2026-08-13
Appointment 2026-08-10
07 Methodology & Data Coverage
DatasetCountFreshness
Credit Ratings (current) 4 2024-10-31
Rating Actions History 0
Secondary-Market Trades 1 2026-08-06
Reg52(4) Payment Disclosures 0

Methodology version 1.0. See full methodology for sources and limitations.

Related Issuers

All issuers →
Frequently Asked Questions
How many active bonds does Mankind Pharma Limited have?

Mankind Pharma Limited currently has 2 active bonds with coupons 7.97% - 7.99%, maturities spanning 2026 - 2027.

What is Mankind Pharma Limited's credit rating?

The most recent rating on Mankind Pharma Limited's bonds is AA (CRISIL), published by CRISIL, ICRA.

Are Mankind Pharma Limited's bonds secured?

Of the 2 bonds with a disclosed security status, 2 are secured (100%) and 0 are unsecured.

When do Mankind Pharma Limited's bonds mature?

Mankind Pharma Limited's active bonds mature between 2026 - 2027; the nearest matures in 2026-10; the average tenure is 0.7 Yrs.

What is the average coupon on Mankind Pharma Limited's bonds?

The average coupon across Mankind Pharma Limited's 2 active bonds is 7.98%.

Disclaimer: This page aggregates publicly available data about Mankind Pharma Limited for informational purposes only. Ratings shown are the opinion of the issuing rating agency and are not buy/sell recommendations. RetailBonds.in does not issue its own ratings or investment advice. Verify all data against the issuer’s offer document before transacting.